Ketoprofen

Company
Schein Pharmaceutical

Approval Status
Approved December 1997

Treatment for
anti-inflammatory

Areas
Musculoskeletal , Rheumatology

Ketoprofen, the generic equivalent of Wyeth Ayerst's Oruvail, has received approval as a non-steroidal anti-inflammatory. Ketoprofen will be available in 200 mg extended release capsules.

Ketoprofen Drug Information

The Ketoprofen drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top